Menu
Yiling Parmaceutical Group logo

Yiling Parmaceutical Group

Free member Since 2009

Beijing, China

It is firstly used to treat coronary heart disease and angina heart disease in the guidance of the collateral disease theory in China. With the effective rate of 96.49% for symptom caused by coronary heart disease and angina heart disease and 91%...

Send your message to this supplier
Ren Xie ( Yiling Parmaceutical Group )
(20~4000 Characters)

Find related suppliers